GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
37.61
+0.04 (0.11%)
May 16, 2025, 10:35 AM - Market open
GSK Revenue
GSK had revenue of 7.52B GBP in the quarter ending March 31, 2025, with 2.08% growth. This brings the company's revenue in the last twelve months to 31.53B, up 2.57% year-over-year. In the year 2024, GSK had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.53B GBP
Revenue Growth
+2.57%
P/S Ratio
1.80
Revenue / Employee
459,412 GBP
Employees
68,629
Market Cap
73.48B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
GSK News
- 2 days ago - GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion - WSJ
- 2 days ago - GSK to buy efimosfermin for up to $2 billion - Reuters
- 2 days ago - GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) - Business Wire
- 3 days ago - ITeos, GSK discontinue lung cancer therapy development - Reuters
- 3 days ago - India's GlaxoSmithKline Pharma reports profit rise on strong demand - Reuters
- 3 days ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC
- 4 days ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ
- 4 days ago - Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%' - The Guardian